Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
1.120
+0.050 (4.67%)
At close: Mar 9, 2026, 4:00 PM EDT
1.090
-0.030 (-2.68%)
After-hours: Mar 9, 2026, 4:46 PM EDT
Estrella Immunopharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| Market Capitalization | 47 | 43 | 38 | 19 | - | - |
| Market Cap Growth | -12.67% | 13.67% | 101.23% | - | - | - |
| Enterprise Value | 47 | 42 | 33 | 21 | - | - |
| Last Close Price | 1.07 | 1.20 | 1.05 | 10.84 | 10.00 | - |
| PB Ratio | - | 302.06 | 8.94 | -2.81 | - | - |
| P/TBV Ratio | - | 302.06 | 8.94 | - | - | - |
| Debt / Equity Ratio | 0 | 0.03 | 0.00 | 0.00 | - | - |
| Net Debt / Equity Ratio | 0.17 | -6.35 | -0.97 | 0.36 | -1.03 | - |
| Quick Ratio | 0.12 | 0.31 | 23.05 | 0.25 | 4.32 | - |
| Current Ratio | 0.15 | 0.55 | 24.65 | 0.28 | 5.20 | - |
| Return on Assets (ROA) | - | - | -122.12% | -174.75% | - | - |
| Return on Capital Employed (ROCE) | 137.30% | -6160.10% | -171.10% | 165.20% | -42.40% | - |
| Earnings Yield | -27.94% | -20.39% | -19.14% | -58.56% | - | - |
| Buyback Yield / Dilution | -2.36% | -34.73% | -8764.81% | - | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.